RUNX1-MUC13 Interaction Activates Wnt/β-Catenin Signaling Implications for Colorectal Cancer Metastasis
Open Access
- 1 January 2024
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 20 (12) , 4999-5026
Abstract
Background: Colorectal cancer (CRC) remains a significant global health challenge, often characterized by late-stage metastasis and poor prognosis. The Runt-related transcription factor 1 (RUNX1) plays a dual role as both an oncogene and a tumor suppressor in various cancers, including CRC. However, the specific regulatory mechanisms of RUNX1 in CRC, particularly its direct roles, are not fully understood.Keywords
This publication has 70 references indexed in Scilit:
- An orthotopic endometrial cancer mouse model demonstrates a role for RUNX1 in distant metastasisInternational Journal of Cancer, 2009
- Expression and Functions of Transmembrane Mucin MUC13 in Ovarian CancerCancer Research, 2009
- Wnt/β-Catenin Signaling in Development and DiseaseCell, 2006
- Epidemiology and Management of Liver Metastases From Colorectal CancerAnnals of Surgery, 2006
- Phosphorylation of β-Catenin by Cyclic AMP-dependent Protein KinaseJournal of Biological Chemistry, 2006
- Overexpression of MUC13 is associated with intestinal‐type gastric cancerCancer Science, 2005
- Structure and regulated expression of mammalian RUNX genesOncogene, 2004
- Caught up in a Wnt storm: Wnt signaling in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2003
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Factors influencing the natural history of colorectal liver metastasesThe Lancet, 1994